相似文献
1
Bioactive scaffolds for engineering vascularized cardiac tissues.
Macromol Biosci. 2010 Nov 10;10(11):1286-301. doi: 10.1002/mabi.201000202.
2
Scaffolds with covalently immobilized VEGF and Angiopoietin-1 for vascularization of engineered tissues.
Biomaterials. 2010 Jan;31(2):226-41. doi: 10.1016/j.biomaterials.2009.09.039. Epub 2009 Oct 2.
3
Defining conditions for covalent immobilization of angiogenic growth factors onto scaffolds for tissue engineering.
J Tissue Eng Regen Med. 2011 Jan;5(1):69-84. doi: 10.1002/term.292. Epub 2010 Aug 17.
4
Controlled release of chitosan/heparin nanoparticle-delivered VEGF enhances regeneration of decellularized tissue-engineered scaffolds.
Int J Nanomedicine. 2011;6:929-42. doi: 10.2147/IJN.S18753. Epub 2011 May 2.
5
FGF-2 and VEGF functionalization of starPEG-heparin hydrogels to modulate biomolecular and physical cues of angiogenesis.
Biomaterials. 2010 Nov;31(31):7985-94. doi: 10.1016/j.biomaterials.2010.07.021. Epub 2010 Aug 3.
6
Covalently-immobilized vascular endothelial growth factor promotes endothelial cell tubulogenesis in poly(ethylene glycol) diacrylate hydrogels.
J Biomater Sci Polym Ed. 2009;20(12):1763-79. doi: 10.1163/156856208X386381.
7
Biodegradable collagen patch with covalently immobilized VEGF for myocardial repair.
Biomaterials. 2011 Feb;32(5):1280-90. doi: 10.1016/j.biomaterials.2010.10.007. Epub 2010 Oct 29.
8
Bioactive electrospun fibers of poly(glycerol sebacate) and poly(ε-caprolactone) for cardiac patch application.
Adv Healthc Mater. 2015 Sep 16;4(13):2012-25. doi: 10.1002/adhm.201500154. Epub 2015 Aug 13.
9
The effect of controlled expression of VEGF by transduced myoblasts in a cardiac patch on vascularization in a mouse model of myocardial infarction.
Biomaterials. 2013 Jan;34(2):393-401. doi: 10.1016/j.biomaterials.2012.09.038. Epub 2012 Oct 16.
10
Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF.
Biomaterials. 2007 Feb;28(6):1123-31. doi: 10.1016/j.biomaterials.2006.10.029. Epub 2006 Nov 20.
引用本文的文献
1
A Critical Review on Classified Excipient Sodium-Alginate-Based Hydrogels: Modification, Characterization, and Application in Soft Tissue Engineering.
Gels. 2023 May 22;9(5):430. doi: 10.3390/gels9050430.
2
Chorioallantoic Membrane Assay at the Cross-Roads of Adipose-Tissue-Derived Stem Cell Research.
Cells. 2023 Feb 12;12(4):592. doi: 10.3390/cells12040592.
3
Engineering the Cellular Microenvironment of Post-infarct Myocardium on a Chip.
Front Cardiovasc Med. 2021 Jul 14;8:709871. doi: 10.3389/fcvm.2021.709871. eCollection 2021.
4
Collagen-Based Tissue Engineering Strategies for Vascular Medicine.
Front Bioeng Biotechnol. 2019 Jul 12;7:166. doi: 10.3389/fbioe.2019.00166. eCollection 2019.
5
Heparin-Modified Collagen Gels for Controlled Release of Pleiotrophin: Potential for Vascular Applications.
Front Bioeng Biotechnol. 2019 Apr 9;7:74. doi: 10.3389/fbioe.2019.00074. eCollection 2019.
6
Hierarchical Assembly of Bioactive Amphiphilic Molecule Pairs into Supramolecular Nanofibril Self-Supportive Scaffolds for Stem Cell Differentiation.
J Am Chem Soc. 2016 Nov 16;138(45):15027-15034. doi: 10.1021/jacs.6b09014. Epub 2016 Nov 3.
7
Micropatterning Alginate Substrates for Cardiovascular Muscle on a Chip.
Adv Funct Mater. 2013 Aug 12;23(30):3738-3746. doi: 10.1002/adfm.201203319.
8
Control of crosslinking for tailoring collagen-based scaffolds stability and mechanics.
Acta Biomater. 2015 Oct;25:131-142. doi: 10.1016/j.actbio.2015.07.034. Epub 2015 Jul 26.
9
Physiologically inspired cardiac scaffolds for tailored in vivo function and heart regeneration.
Biomed Mater. 2015 May 13;10(3):034003. doi: 10.1088/1748-6041/10/3/034003.
10
Self-assembling peptide scaffolds as innovative platforms for drug and cell delivery systems in cardiac regeneration.
Drug Deliv Transl Res. 2013 Aug;3(4):330-5. doi: 10.1007/s13346-012-0125-8.
本文引用的文献
1
Covalently immobilized biosignal molecule materials for tissue engineering.
Soft Matter. 2007 Dec 11;4(1):46-56. doi: 10.1039/b708359a.
2
Defining conditions for covalent immobilization of angiogenic growth factors onto scaffolds for tissue engineering.
J Tissue Eng Regen Med. 2011 Jan;5(1):69-84. doi: 10.1002/term.292. Epub 2010 Aug 17.
3
Photocrosslinkable chitosan modified with angiopoietin-1 peptide, QHREDGS, promotes survival of neonatal rat heart cells.
J Biomed Mater Res A. 2010 Oct;95(1):105-17. doi: 10.1002/jbm.a.32808.
4
Influence of substrate stiffness on the phenotype of heart cells.
Biotechnol Bioeng. 2010 Apr 15;105(6):1148-60. doi: 10.1002/bit.22647.
5
Engineering surfaces for site-specific vascular differentiation of mouse embryonic stem cells.
Acta Biomater. 2010 Jun;6(6):1904-16. doi: 10.1016/j.actbio.2009.12.005. Epub 2009 Dec 11.
6
Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue.
Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16568-73. doi: 10.1073/pnas.0908381106. Epub 2009 Sep 17.
7
Scaffolds with covalently immobilized VEGF and Angiopoietin-1 for vascularization of engineered tissues.
Biomaterials. 2010 Jan;31(2):226-41. doi: 10.1016/j.biomaterials.2009.09.039. Epub 2009 Oct 2.
8
Geometry and force control of cell function.
J Cell Biochem. 2009 Dec 1;108(5):1047-58. doi: 10.1002/jcb.22355.
9
Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in Swine.
J Am Coll Cardiol. 2009 Sep 8;54(11):1014-23. doi: 10.1016/j.jacc.2009.06.010.
10
Prevascularization of cardiac patch on the omentum improves its therapeutic outcome.
Proc Natl Acad Sci U S A. 2009 Sep 1;106(35):14990-5. doi: 10.1073/pnas.0812242106. Epub 2009 Aug 24.
Zotero 插件